Skip to main content
VulnerabilityPublished

CVE-2026-134434: frappe erpnext · Missing Authorization

Affects frappe erpnextSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 8.3 High : upgrade to 16.36.0 soon.

Data as of 21 Nov 2026, 16:45 UTC

CVSS 4.0 base score
8.3High
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (VulnCheck)CVSS 4.08.3
CNA (VulnCheck)CVSS 3.17.7
Patch
Available – fixed in 16.36.0
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:H/VA:N/SC:N/SI:H/SA:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 21 Nov 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 20 Nov 2026.

What to do

Upgrade frappe erpnext to 16.36.0.

Affected software

ProductAffectedFixed in
frappeerpnextAffected
  • >=16.0.0 <16.36.0
Fixed in
  • 16.36.0

AI-suggested

Upgrade Frappe ERPNext to version 16.36.0 or later, where this missing authorization vulnerability is fixed. No other specific mitigations are indicated. Since this is an authorization flaw, applying the official patch is the recommended remediation.

Description

CVE-2026-134434 is a missing authorization vulnerability in Frappe ERPNext versions 16.0.0 up to but not including 16.36.0. It affects the Manufacturing module endpoint, allowing authenticated users without proper record-level write permissions to cancel Stock Reservation Entries. This enables low-privilege attackers to release reserved stock by targeting manufacturing documents outside their user permissions, potentially disrupting stock allocation processes.

References

Community reviews

Loading reviews…